TheraNova

TheraNova operates as a capital-efficient venture-studio model for medical device and digital health innovation, having spun out 20 companies since its 2006 founding. It boasts a strong track record with over $400M raised for its portfolio, 12 FDA clearances/approvals, and more than 120 granted US patents. The company leverages a shared R&D model and deep in-house expertise across engineering, clinical, regulatory, and IP domains to rapidly develop and de-risk technologies for large markets with unmet needs.

Integrated venture-studio platform providing full-service medical device development from concept to commercialization, combining engineering (mechanical, electrical, software), rapid prototyping, clinical/regulatory strategy, IP, and quality systems in a shared, capital-efficient R&D model.

TheraNova competes with other medtech incubators, venture studios, and corporate venture arms, as well as consultancies offering development services. Its differentiation lies in its full-stack, integrated capabilities from concept to FDA clearance, its strong clinical leadership, and its proven track record of spinning out funded companies with regulatory success.